Edition:
United States

Evolus Inc (EOLS.OQ)

EOLS.OQ on NASDAQ Stock Exchange Global Market

22.44USD
25 May 2018
Change (% chg)

$-1.36 (-5.71%)
Prev Close
$23.80
Open
$24.71
Day's High
$28.32
Day's Low
$22.41
Volume
283,904
Avg. Vol
--
52-wk High
$28.32
52-wk Low
$6.78

Chart for

About

Evolus, Inc. is a medical aesthetics company. The Company is focused on providing physicians and aesthetic procedures and treatments. It also focuses on offering the self-pay aesthetic market and its product candidate, PrabotulinumtoxinA (DWP-450), is an injectable 900 kilodalton, or kDa, botulinum toxin type designed to address... (more)

Overall

Beta: --
Market Cap(Mil.): $530.49
Shares Outstanding(Mil.): 23.64
Dividend: --
Yield (%): --

Financials

  EOLS.OQ Industry Sector
P/E (TTM): -- 238.69 33.30
EPS (TTM): -0.15 -- --
ROI: -- -7.54 13.04
ROE: -- -10.33 14.90

BRIEF-Evolus Announces Pricing Of Initial Public Offering Of Common Stock

* EVOLUS, INC. ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING OF COMMON STOCK

Feb 07 2018

BRIEF-Evolus Inc Sees IPO Priced To Be Between $12 And $14 Per Share

* EVOLUS INC SEES IPO OF 5 MILLION SHARES PRICED TO BE BETWEEN $12 AND $14 PER SHARE – SEC FILING‍​

Jan 29 2018

Earnings vs. Estimates